ArticleCurrent genomics2025
MLA-ac4C: A N4-Acetylcytidine Site Prediction Model Based on Multi-Layer Attention, Bidirectional GRU, and DenseNet.
Article in Current genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: N4-acetylcytidine (ac4C) is a highly conserved post-transcriptional modification found in mRNA, known to play a critical role in the regulation of mRNA translation. Traditional experimental approaches for identifying ac4C sites are both time-consuming and costly, underscoring the need for more efficient computational prediction methods. Although various deep learning models have been proposed for ac4C site prediction, most rely on ordinary encoding strategies and simplistic network architectures, which limit their ability to capture high-dimensional features of mRNA sequences. In this study, we propose a novel framework that combines multiple encoding schemes with a hierarchical network structure to improve prediction accuracy. Methods: We developed a new deep learning model, MLA-ac4C, based on a dual-pathway architecture. In the first pathway, one-hot encoding combined with positional encoding is used to represent the sequence, followed by a Bidirectional Gated Recurrent Unit (Bi-GRU) network to extract global features. In the second pathway, a hybrid encoding scheme integrating nucleotide chemical property (NCP), Electron-Ion Interaction Pseudopotential (EIIP), and Pseudo K-Tuple Nucleotide Composition (PseKNC) is used, and local features are extracted using Densely Connected Convolutional Networks (DenseNet). A multi-layer attention mechanism is then applied to integrate the features from both pathways and capture high-level representations for classification. Results: Rigorous evaluation on an independent test dataset shows that MLA-ac4C achieves superior performance, with Sensitivity (Sn), Specificity (Sp), Accuracy (Acc), Matthews correlation coefficient (MCC), and Area Under The ROC Curve (AUROC) reaching 83.88%, 85.14%, 84.51%, 69.03%, and 92.74%, respectively. These results outperform those of existing state-of-the-art models. Conclusion: We present MLA-ac4C, a deep learning model based on Bi-GRU, DenseNet, and a multi-layer attention mechanism. Experimental results demonstrate that it provides a more accurate and efficient approach for predicting ac4C modification sites compared to existing methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.